| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/02/2023 | 5.77% | Goldman Sachs | $18 → $11 | Maintains | Neutral |
| 10/19/2023 | 92.31% | Wells Fargo | $25 → $20 | Downgrades | Overweight → Equal-Weight |
| 10/19/2023 | 44.23% | TD Cowen | $22 → $15 | Downgrades | Outperform → Market Perform |
| 08/04/2023 | 73.08% | Barclays | $20 → $18 | Maintains | Equal-Weight |
| 05/19/2023 | 39.42% | B of A Securities | $17 → $14.5 | Maintains | Underperform |
| 05/02/2023 | — | Barclays | Downgrades | Overweight → Equal-Weight | |
| 03/29/2023 | 92.31% | UBS | $23 → $20 | Maintains | Neutral |
| 02/17/2023 | 92.31% | Evercore ISI Group | $25 → $20 | Downgrades | Outperform → In-Line |
| 02/07/2023 | 63.46% | B of A Securities | → $17 | Maintains | Underperform |
| 02/06/2023 | 101.92% | Barclays | $20 → $21 | Maintains | Overweight |
| 02/03/2023 | 111.54% | Cowen & Co. | $26 → $22 | Maintains | Outperform |
| 02/02/2023 | 63.46% | B of A Securities | → $17 | Maintains | Underperform |
| 01/27/2023 | 150% | Cowen & Co. | $24 → $26 | Maintains | Outperform |
| 11/04/2022 | 92.31% | Barclays | → $20 | Maintains | Overweight |
| 11/04/2022 | 82.69% | Goldman Sachs | $22 → $19 | Maintains | Neutral |
| 10/21/2022 | — | OTR Global | Upgrades | Negative → Mixed | |
| 09/19/2022 | — | Williams Trading | Upgrades | Sell → Hold | |
| 08/12/2022 | 169.23% | Barclays | $26 → $28 | Maintains | Overweight |
| 07/21/2022 | 92.31% | Goldman Sachs | $26 → $20 | Maintains | Neutral |
| 05/23/2022 | 150% | Barclays | $32 → $26 | Maintains | Overweight |
| 05/20/2022 | 188.46% | Cowen & Co. | $37 → $30 | Maintains | Outperform |
| 04/22/2022 | — | OTR Global | Downgrades | Mixed → Negative | |
| 04/04/2022 | 207.69% | Barclays | $32 → $32 | Maintains | Overweight |
| 04/01/2022 | 207.69% | Barclays | → $32 | Maintains | Overweight |
| 01/24/2022 | — | OTR Global | Downgrades | Positive → Mixed | |
| 01/07/2022 | 236.54% | UBS | $59 → $35 | Downgrades | Buy → Neutral |
| 01/06/2022 | — | Barclays | Upgrades | Equal-Weight → Overweight | |
| 07/23/2021 | — | OTR Global | Upgrades | Mixed → Positive | |
| 07/14/2021 | 342.31% | Goldman Sachs | → $46 | Initiates Coverage On | → Neutral |
| 05/14/2021 | 553.85% | Credit Suisse | $64 → $68 | Maintains | Outperform |
| 04/23/2021 | — | OTR Global | Upgrades | Negative → Mixed | |
| 02/05/2021 | 275% | Goldman Sachs | $26 → $39 | Upgrades | Sell → Neutral |
| 02/05/2021 | — | BTIG | Upgrades | Sell → Neutral | |
| 02/01/2021 | — | Barclays | Downgrades | Overweight → Equal-Weight | |
| 09/30/2020 | — | Cowen & Co. | Upgrades | Market Perform → Outperform | |
| 07/22/2020 | 188.46% | UBS | → $30 | Initiates Coverage On | → Buy |
| 05/15/2020 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 02/10/2020 | 207.69% | DA Davidson | $38 → $32 | Maintains | Neutral |
| 02/10/2020 | 178.85% | Cowen & Co. | $50 → $29 | Downgrades | Outperform → Market Perform |
| 02/10/2020 | 226.92% | Goldman Sachs | $44 → $34 | Downgrades | Buy → Neutral |
| 01/31/2020 | — | OTR Global | Downgrades | Positive → Mixed | |
| 11/25/2019 | 351.92% | Barclays | → $47 | Initiates Coverage On | → Overweight |
| 11/14/2019 | 265.38% | DA Davidson | $42 → $38 | Maintains | Neutral |
| 11/14/2019 | 496.15% | Credit Suisse | $72 → $62 | Maintains | Outperform |
| 11/07/2019 | 303.85% | DA Davidson | $48 → $42 | Downgrades | Buy → Neutral |
| 08/15/2019 | 361.54% | DA Davidson | $42 → $48 | Reiterates | → Buy |
| 05/31/2019 | 351.92% | Goldman Sachs | $65 → $47 | Upgrades | Neutral → Buy |
| 05/30/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 05/20/2019 | — | HSBC | Initiates Coverage On | → Buy | |
| 01/24/2019 | — | Wells Fargo | Downgrades | Outperform → Market Perform | |
| 01/03/2019 | 707.69% | TD Securities | $93 → $84 | Upgrades | Hold → Buy |
| 11/15/2018 | 640.38% | Barclays | $72 → $77 | Maintains | Overweight |
What is the target price for Canada Goose Hldgs (GOOS)?
The latest price target for Canada Goose Hldgs (NYSE: GOOS) was reported by Goldman Sachs on November 2, 2023. The analyst firm set a price target for $11.00 expecting GOOS to rise to within 12 months (a possible 5.77% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Canada Goose Hldgs (GOOS)?
The latest analyst rating for Canada Goose Hldgs (NYSE: GOOS) was provided by Goldman Sachs, and Canada Goose Hldgs maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Canada Goose Hldgs (GOOS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Canada Goose Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Canada Goose Hldgs was filed on November 2, 2023 so you should expect the next rating to be made available sometime around November 2, 2024.
Is the Analyst Rating Canada Goose Hldgs (GOOS) correct?
While ratings are subjective and will change, the latest Canada Goose Hldgs (GOOS) rating was a maintained with a price target of $18.00 to $11.00. The current price Canada Goose Hldgs (GOOS) is trading at is $10.40, which is out of the analyst's predicted range.